Popular antidepressant recalled over high levels of a cancer-causing compound — Live Feedhttps://www.live-feeds.com/feed/popular-antidepressant-recalled-over-high-levels-of-a-cancer-causing-compoundContinuously updated, source-cited coverage. FDA Recalls Nearly 375,000 Bottles of Duloxetine Over Carcinogen Riskhttps://www.live-feeds.com/feed/popular-antidepressant-recalled-over-high-levels-of-a-cancer-causing-compoundhttps://www.live-feeds.com/feed/popular-antidepressant-recalled-over-high-levels-of-a-cancer-causing-compound#u10260Tue, 23 Jun 2026 20:36:09 +0000The FDA has recalled a popular antidepressant due to high levels of a potentially cancer-causing impurity. Breckenridge Pharmaceuticals is recalling its generic version of Cymbalta. The impurity identified in the medication is a nitrosamine.What's confirmed:The FDA recalled nearly 375,000 bottles of the antidepressant duloxetine.The recall was triggered by high levels of a potentially cancer-causing impurity.The impurity detected in the drug is a nitrosamine.Breckenridge Pharmaceuticals is recalling the generic version of Cymbalta.